冠状动脉生物可吸收血管支架成功治疗复发性颈动脉支架内再狭窄及药物洗脱球囊治疗失败：一例报告
Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report.
作者信息
Giordano Arturo, Ferraro Paolo, Corcione Nicola, Messina Stefano, Maresca Gennaro, Coscioni Enrico, Biondi-Zoccai Giuseppe
机构信息
Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy; Unità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano, Italy.
Division of Cardiac Surgery, San Giovanni di Dio e Ruggì D'Aragona Hospital, Salerno, Italy.
出版信息
Int J Surg Case Rep. 2016;21:78-82. doi: 10.1016/j.ijscr.2016.02.035. Epub 2016 Feb 27.
INTRODUCTION
Carotid in-stent restenosis is associated with substantial risk of recurrent restenosis, even after drug-eluting balloon usage.
PRESENTATION OF CASE
We hereby report the case of a patient with recurrent carotid in-stent restenosis and drug-eluting balloon failure treated with a coronary bioresorbable vascular scaffold, achieving a satisfactory acute and long-term result, as disclosed by duplex ultrasound scan performed more than 1 year after the procedure.
DISCUSSION/CONCLUSION: While awaiting for external validation, this clinical vignette supports expanding the armamentarium of endovascular specialists focusing on carotid artery disease, while providing further proof of the safety and efficacy of current bioresorbable vascular scaffolds.
引言
即使使用了药物洗脱球囊，颈动脉支架内再狭窄仍与较高的再狭窄复发风险相关。
病例介绍
我们在此报告一例复发性颈动脉支架内再狭窄且药物洗脱球囊治疗失败的患者，采用冠状动脉生物可吸收血管支架治疗后，经术后1年多的双功超声扫描显示，取得了满意的近期和长期效果。
讨论/结论：在等待外部验证的同时，该临床病例支持扩大专注于颈动脉疾病的血管介入专家的器械库，同时进一步证明了当前生物可吸收血管支架的安全性和有效性。
Zotero 插件